Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

NCT05502783 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Clinical trial was halted prematurely due to low enrollment

Conditions

Immune Mediated Anemia
Immune Mediated Thrombocytopenia
Chronic GVHD

Interventions

DRUG: fostamatinib

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)